Evidence map›Paper›PMID 39692507›Full record

ArticlemSphere2025

Skin-associated

M H Swaney, N Henriquez, T Campbell, J Handelsman, L R Kalan

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in mSphere, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. The forehead and glabella show pronouncedFrontiers in microbiology · 2026
    Article
  2. Review
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

M H SwaneyDepartment of Medical Microbiology and Immunology, School of Medicine and Public Health, University of Wisconsin, Madison, Wisconsin, USA.ORCID 0000-0003-4039-6970
N HenriquezMichael G. DeGroote Institute for Infectious Disease Research, McMaster University, Hamilton, Ontario, Canada.
T CampbellMichael G. DeGroote Institute for Infectious Disease Research, McMaster University, Hamilton, Ontario, Canada.
J HandelsmanWisconsin Institute for Discovery, Madison, Wisconsin, USA.ORCID 0000-0003-3488-5030
L R KalanDepartment of Medical Microbiology and Immunology, School of Medicine and Public Health, University of Wisconsin, Madison, Wisconsin, USA.ORCID 0000-0003-4980-5128

Funding

Novel antimicrobials targeting MDR pathogens from animal microbial symbiontsU19AI142720 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI BUGNI, TIMOTHY S · 2019 to 2023
$30.1M
Elucidating the Role of Microbial Community Dynamics in Wound Repair and RegenerationR35GM137828 · NIGMS · UNIVERSITY OF WISCONSIN-MADISON · PI KALAN, LINDSAY ROBYN · 2020 to 2021
$750k
Defining the role of cobamides in skin microbiome dynamicsF31AR079846 · NIAMS · UNIVERSITY OF WISCONSIN-MADISON · PI SWANEY, MARY HANNAH · 2022 to 2023
$51k
NIAID NIH HHS U19 AI142720NIAMS NIH HHS F31 AR079846NIGMS NIH HHS R35 GM137828
6 · The paper itself

Abstract

The underlying interactions that occur to maintain skin microbiome composition, function, and overall skin health are largely unknown. Often, these types of interactions are mediated by microbial metabolites. Cobamides, the vitamin B IMPORTANCE: The human skin serves as a crucial barrier for the body and hosts a diverse community of microbes known as the skin microbiome. The interactions that occur to maintain a healthy skin microbiome are largely unknown but are thought to be driven in part, by nutrient sharing between species in close association. Here we show that the skin-associated bacteria

Indexed as

CobamidesCorynebacteriumSkinCobaltCoculture TechniquesEscherichia coliHumansMicrobiotaCobaltCobamidescobamidecorynebacteriumnutrient sharingskin microbiome

Identifiers

PMID39692507
PMCPMC11774034

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.